History:
In 2001, an idea about treatment of HIV infected and AIDS patients was proposed in Russia. From the first stage, a scientific group was formed including one Russian and 4 expert Iranian specialists to conduct the research process in Iran. At first, a complete toxicology analysis of the component was preformed in one of the best toxicology laboratories in Moscow (the laboratory was approved by the Ministry of Health and Medical Education). The toxicology studies were repeated in Iran and next phases of preclinical and clinical researches were performed.
Drug effects:
 The herbal extract IMODTM has immune system modulatory effects. In a study on HIV infected patients entering AIDS phase with CD4 count less than 200, after a 1-3 months treatment course, CD4 count increased significantly thus the patients exited through symptomatic phase of AIDS and there was no need for their hospitalization. This effect remained stable for a long period.
Administration and Dosage:
Daily dosage of IMODTM is a 4 ml vial diluted in 100 ml 0.9% sodium chloride solution (Normal saline) used intravenously. A complete course of treatment is maximum 90 days.
Adverse Effects:
No significant adverse effect has been detected so far.
Contraindications:
At present according to limitation of studies, this drug is not recommended in pregnant women and in the period of lactation. |
|
|
